Bone Biologics Stock Forecast
NASDAQ: BBLGHealthcareBiotechnologyUSD
0.4691-0.0184 (-3.77%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
BBLG analyst consensus
Consensus
none
Avg. price target
$12.20+2500.72%
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
The average 12-month price target is $12.20, with a high estimate of $12.20 and a low estimate of $12.20. The average target implies upside of 2500.7% from the current price of $0.4691. The spread between the highest and lowest targets is 0.0%, a relatively narrow range.
Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for BBLG.
Summary generated from market data by MetaCap's automated system. Methodology
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $12.20 | +2500.72% |
| Average target | $12.20 | +2500.72% |
| High target | $12.20 | +2500.72% |